Cumberland Pharmaceuticals (CPIX) Stock: Buy, Sell, or Hold?
CPIX - Cumberland Pharmaceuticals Inc
$8.43
0.26 (3.18%)
▲
5d:
+11.8%
30d:
+6.17%
90d:
+27.53%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 03, 2026
11d
Get Alerted When CPIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CPIX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CPIX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CPIX is currently trading at $8.43, which is considered extended relative to its 30-day fair value range of $6.94 to $7.89.
Technical Outlook: Technically, CPIX is in a uptrend. Immediate support is located at $6.30, while resistance sits at $8.73. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: CPIX scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CPIX is in a uptrend. Immediate support is located at $6.30, while resistance sits at $8.73. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: CPIX scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$6.94 -
$7.89
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
37.5%
All Signals
- BEARISH: Price extended above range (+6.8% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- NEUTRAL: Near Wall St target ($8.50)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$6.94 -
$7.89
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$1.26
(15.0%)
Support & Resistance Levels
Support Level
$6.30
Resistance Level
$8.73
Current Trend
Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
50.00
Wall Street Target
$8.50
(+4.0%)
Revenue Growth (YoY)
-56.3%
Profit Margin
-24.6%
Share & Embed Analysis
Last updated: October 22, 2026 12:42 PM ET
Data refreshes hourly during market hours. Next update: 1:42 PM
Data refreshes hourly during market hours. Next update: 1:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CPIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$207 | 60 HOLD |
|
ELAN
Elanco Animal Health |
STRONG BUY
16 analysts |
$31 | 49 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 67 BUY |
|
ALKS
Alkermes Plc |
STRONG BUY
19 analysts |
$56 | 43 HOLD |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$65 | 59 HOLD |
